Publications Office of the EU
Czechia-Hradec Králové: Antineoplastic agents - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Czechia-Hradec Králové: Antineoplastic agents

  • Announced
    03/08/2020
  • Estimated published
    09/09/2020
  • Published
    14/10/2020
  • Deadline
    30/10/2020
  • Opening of tenders
    30/10/2020
  • Awarded
    17/12/2020
  • Today
    18/08/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Fakultní nemocnice Hradec Králové
Place of performance
NUTS code: CZ052 Královéhradecký kraj
Location of buyer
NUTS code: CZ052 Královéhradecký kraj
Business sector (Main CPV)
33652100 Antineoplastic agents
Total estimated contract value (excluding VAT)
38,856,845.00 CZK
Total final contract value (excluding VAT)
38,755,275.60 CZK
Tender reference number
Not available
Description

Předmětem zakázky jsou průběžné dodávky léčivých přípravků s obsahem rituximabu po dobu 4 let dle aktuálních potřeb zadavatele.

Submission Method
Electronic via:
https://www.egordion.cz/nabidkaGORDION/profilFNHK
Tenders may be submitted
Submission for all lots
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
30/10/2020 10:00
Place of performance
Award method
Lowest price
Estimated value
38,856,845.00 CZK
Final contracted value
38,755,275.60 CZK
Award of contract
Official name: Roche s.r.o.
Postal address: Sokolovská 685/136f
Town: Praha 8
Postal code: 186 00
Country: CZE
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.